Guided Therapeutics (GTHP) Non-cash Items (2011 - 2025)

Guided Therapeutics' Non-cash Items history runs 15 years deep, the most recent figure standing at $2.1 million for Q3 2025.

• In Q3 2025, Non-cash Items fell 4.38% year-over-year to $2.1 million; the TTM figure through Sep 2025 stood at $2.1 million (down 4.38% YoY), while the FY2024 annual figure was $1.9 million, up 6.21% from the prior year.
• Non-cash Items came in at $2.1 million for Q3 2025 at Guided Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $2.4 million in Q1 2025 to a low of -$224000.0 in Q2 2021.
• A 5-year average of $1.7 million and a median of $1.9 million in 2023 frame the typical range for Non-cash Items.
• On a YoY basis, Non-cash Items climbed as much as 127.81% in 2021 and fell as far as 103.53% in 2021.
• Guided Therapeutics' Non-cash Items stood at -$224000.0 in 2021, then surged by 688.43% to $1.3 million in 2022, then soared by 37.42% to $1.8 million in 2023, then advanced by 6.21% to $1.9 million in 2024, then increased by 7.98% to $2.1 million in 2025.
• According to Business Quant data, Non-cash Items over the past three periods registered $2.1 million, $2.2 million, and $2.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison